Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Clinical trial NCT06646562 · RECRUITING

Trial details

NCT number: NCT06646562
Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1 Infected Adults with Controlled Viremia

Start date: 2025-03-03
Primary completion: 2026-01-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.